Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

The future of healthcare is defined by this blend of technology and human expertise, offering new hope for a more efficient ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Organ donation registration can be completed through the Ohio Bureau of Motor Vehicles. Living donors can contact one of two ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Researchers have demonstrated the feasibility of a morphological-based approach to interpreting spatial transcriptomic (ST) data, helping to improve understanding of the lesions that occur in chronic ...

The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

A recent study on kidney disease found that nearly half of patients with advanced chronic kidney disease (CKD) in the country ...

Denmark: A recent study published in the Journal of Diabetes and its Complications has explored the role of kidney fat ...